By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Medical Answers > Does Mavenclad cause hair loss?

Does Mavenclad cause hair loss?

Answers by TheMediTary.Com - Last updated: 13-Jul-2023

Hair loss is an infrequent side effect with Mavenclad (generic name: cladribine), an oral medicine used in the treatment of multiple sclerosis. In clinical studies, hair loss occurred in 3% (3 out of every 100) of patients treated with Mavanclad compared to 1% of patients receiving a placebo (inactive) treatment. Hair loss is also referred to medically as alopecia.

Hair loss if not usually a symptom of multiple sclerosis (MS). However, in addition to medications, stress on the body, physically or mentally, can lead to hair thinning or hair loss in some people. Hair loss is usually a temporary side effect for most patients.

Most people lose about 50 to 100 hairs per day and this is not typically obvious. If you are experiencing noticeable hair loss, contact your doctor for an evaluation. It may be that another medicine or medical condition may be leading to your hair loss.

See you doctor if:

  • your hair starts to fall out suddenly or in clumps
  • you have specific patches without hair or bald spots
  • your scalp is red or itchy, is bleeding or has lesions
  • you're worried about your hair loss

Which MS drugs lead to hair loss or hair thinning?

Several other medicines used in the treatment of multiple sclerosis (MS) have been reported to lead to hair thinning or hair loss, in addition to Mavenclad.

These agents include (with incidence, if known):

  • Aubagio (teriflunomide): up to 13%
  • Avonex (interferon beta-1a): 4%
  • Betaseron (interferon beta-1b): <1%
  • Copaxone (glatiramer): incidence unknown (case report)
  • Gilenya (fingolimod): 3%
  • Tecfidera (dimethyl fumarate): incidence unknown (case report)

Bottom Line

  • Hair loss (alopecia) is not a frequent side effect with Mavenclad, but it has been reported.
  • In clinical studies, alopecia occurred in 3% of Mavenclad-treated patients (3 out of every 100) compared to 1% of placebo patients.
  • Hair loss can occur with other medications, too, including other MS drugs. If you have concerns about hair loss, contact your doctor for an evaluation.

This is not all the information you need to know about Mavenclad (cladribine) for safe and effective use. Review the full Mavenclad prescription information here, and discuss this information with your doctor or other health care provider.

Share this Article

Featured questions

  • How quickly does Mavenclad work?
  • Is Mavenclad a chemotherapy drug?
  • Does Mavenclad have a Black Box Warning?
  • Does Mavenclad cause weight gain?
  • How effective is Mavenclad for MS?
  • How is Mavenclad given/administered?
  • Can these drugs be used in Thalassemia patients?
  • How does Lupron (leuprolide) work for prostate cancer?
  • What is the consideration to use nifidepine over amlodipine?
  • Hypertrophic cardiomyopathy/mechanical heart valve?
  • I have been on 400mg of tramadol a day for 20 years, decided its time to come off them
  • Cetirizine - can cetirizine be taken for long periods of time?
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch (Hydrocortisone topical)
Centrum Adult (Multivitamins and minerals)
Crovalimab
Cyltezo Prefilled Syringe (Adalimumab)
Zepbound Pen (Tirzepatide)
Mylanta One (Calcium carbonate, magnesium hydroxide, and simethicone)
Uretron Ds (Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate)
Medihoney Wound And Burn Dressing (Topical emollients)
Lidotrode
Libervant (Diazepam (buccal))
Moderna Covid-19 (Covid-19 (6m-11y) vaccine, moderna (2024-2025))
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by